Press Releases

  • Jul. 2021
    Strong growth: Leukocare moves into new headquarters at the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried/Planegg
  • Jul. 2021
    Auf Wachstumskurs: Leukocare bezieht neuen Firmenstandort am Innovations- und Gründungszentrum Biotechnologie (IZB) in Martinsried/Planegg
  • Jun. 2021
    Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities
  • Jun. 2021
    Leukocare gibt Finanzierungsrunde in Höhe von 17,5 Mio. US-Dollar zum weiteren Ausbau des US-Geschäfts und der Bioinformatik-Aktivitäten bekannt
  • May. 2021
    Leukocare cooperates with the Drug Safety Foundation and the Central Laboratory of German Pharmacists to investigate the stability of monoclonal antibodies during shipment and storage
  • May. 2021
    Leukocare appoints Dr. Georg Dönges as Chief Financial Officer
  • Mar. 2021
    Leukocare and Formycon cooperate in the development of high-quality biopharmaceuticals
  • Mar. 2021
    Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
  • Mar. 2021
    Leukocare and Malvern collaborate on stabilization and formulation development of COVID-19 vaccines
  • Feb. 2021
    Leukocare appoints Professor Ulrike Protzer as member to the Scientific Advisory Board